secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001099800-24-000031
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences Chairman Michael Mussallem to Retire, Nicholas Valeriani to Succeed
--------------------------------------------------------------------------------

- Michael A. Mussallem will retire as Non-Executive Chairman and director effective May 7, 2024, the date of the annual meeting.
- Nicholas J. Valeriani, an independent director, is expected to be appointed as Chairman of the Board.
- Martha H. Marsh will not stand for re-election due to reaching retirement age under company guidelines.
- The changes were announced on March 26, 2024, in an 8-K filing by Edwards Lifesciences (NYSE: EW).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980024000031/0001099800-24-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980024000031/ew-20240326.htm
  HTML page:      https://secwatch.observer/filing/0001099800-24-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer